Medco Research to explore uses of genetic biomarkers; Study explores role of proteins as biomarker for colon cancer

>  The Medco Research Institute and SureGene are collaborating on new research that sheds light on the connection between variations in genetic biomarkers and the efficacy of antipsychotic therapies. Report

> A new study explores the role of hydrophobic proteins as biomarkers for colon cancer. Release

> The FDA has selected Ariana Pharma's Knowledge Extraction Management decision-support platform for biomarker signature validation work. Ariana release

> The Biomedical Advanced Research and Development Authority awarded Menssana Research a contract for $4.2 million plus options--which could total $22.84 million, if exercised--to develop a breath test for radiation exposure. Menssana Research has developed a breathalyzer which can detect several hundred different chemical compounds in normal human breath. Menssana release

> Emerald BioStructures and SomaLogic will collaborate on new technology needed to design and optimize SOMAmers for use in diagnostics and biomarker discovery. Story

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.